We are live on ! Find out more
YARW

Yarrow Bioscience, Inc. Common Stock

81 hedge funds and large institutions have $154M invested in Yarrow Bioscience, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

415% more call options, than puts

Call options by funds: $845K | Put options by funds: $164K

11% more capital invested

Capital invested by funds: $138M → $154M (+$15.6M)

0.03% more ownership

Funds ownership: 0.01%0.05% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 23

17% less funds holding

Funds holding: 9881 (-17)

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

Holders
81
Holders Change
-17
Holders Change %
-17.35%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
15
Increased
20
Reduced
23
Closed
31
Calls
$845K
Puts
$164K
Net Calls
+$681K
Net Calls Change
+$681K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$6K -$36.3K -5 -83%
IA
77
IFP Advisors
Florida
$4K +$7.25K +1 New
Osaic Holdings
78
Osaic Holdings
Arizona
$3K
RAM
79
Riggs Asset Management
Pennsylvania
$3K +$7.25K +1 New
IAIM
80
International Assets Investment Management
Florida
$2K
CAPTRUST Financial Advisors
81
CAPTRUST Financial Advisors
North Carolina
$1K
CCM
82
Cribstone Capital Management
Maine
$1K
Daiwa Securities Group
83
Daiwa Securities Group
Japan
$1K
EWM
84
Edge Wealth Management
New York
$1K
AIG
85
American International Group
New York
$145 +$7.25K +1 +4%
Nisa Investment Advisors
86
Nisa Investment Advisors
Missouri
$3
6CM
87
683 Capital Management
New York
-$9.43M -1,658 Closed
Jacobs Levy Equity Management
88
Jacobs Levy Equity Management
New Jersey
-$1.28M -225 Closed
Renaissance Technologies
89
Renaissance Technologies
New York
-$725K -127 Closed
SC
90
Saltoro Capital
Texas
-$571K -100 Closed
SCM
91
Silverarc Capital Management
Massachusetts
-$552K -97 Closed
FMBTD
92
First Midwest Bank Trust Division
Illinois
-$471K -83 Closed
PVH
93
Psagot Value Holdings
Israel
-$427K -75 Closed
Connor, Clark & Lunn Investment Management (CC&L)
94
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$411K -72 Closed
PAM
95
Premier Asset Management
Illinois
-$289K -51 Closed
Ohio Public Employees Retirement System (OPERS)
96
Ohio Public Employees Retirement System (OPERS)
Ohio
-$105K -18 Closed
CS
97
Credit Suisse
Switzerland
-$69K -12 Closed
JGC
98
J. Goldman & Co
New York
-$64K -11 Closed
Dimensional Fund Advisors
99
Dimensional Fund Advisors
Texas
-$57K -10 Closed
SG Americas Securities
100
SG Americas Securities
New York
-$55K -10 Closed

YARW Hedge Fund Activity: Q1 2021 in Review

81 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q1 2021, worth a combined $154M — up 11% from $138M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of YARW and 15 opened new positions — a net loss of 16 holders — while 23 trimmed existing stakes and 20 added.

The largest buyer was Perceptive Advisors, adding an estimated $8.5M. The largest seller was 683 Capital Management, exiting entirely with an estimated $9.43M sold.

  • 81 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q1 2021, down from 98 in Q4 2020.
  • Funds reported $154M of Yarrow Bioscience, Inc. Common Stock stock for Q1 2021, up 11% quarter-over-quarter.
  • 15 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q1 2021 and 31 closed out, a net change of -16 holders.
  • The largest Yarrow Bioscience, Inc. Common Stock buyer in Q1 2021 was Perceptive Advisors, an estimated $8.5M added.
  • The largest Yarrow Bioscience, Inc. Common Stock seller in Q1 2021 was 683 Capital Management, an estimated $9.43M sold.

Based on aggregated 13F filings for Q1 2021.